Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma.

Huang SY, Lin HH, Lin CW, Li CC, Yao M, Tang JL, Hou HA, Tsay W, Chou SJ, Cheng CL, Tien HF

DOI: 10.18632/oncotarget.11519
Published: 2016 Sep 20
Container: Oncotarget
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.11519,
  title = {Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma.},
  author = {Huang SY and Lin HH and Lin CW and Li CC and Yao M and Tang JL and Hou HA and Tsay W and Chou SJ and Cheng CL and Tien HF},
  year = {2016},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.11519},
  url = {https://doi.org/10.18632/oncotarget.11519}
}

RIS

TY  - JOUR
TI  - Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma.
AU  - Huang SY
AU  - Lin HH
AU  - Lin CW
AU  - Li CC
AU  - Yao M
AU  - Tang JL
AU  - Hou HA
AU  - Tsay W
AU  - Chou SJ
AU  - Cheng CL
AU  - Tien HF
PY  - 2016
JO  - Oncotarget
DO  - 10.18632/oncotarget.11519
UR  - https://doi.org/10.18632/oncotarget.11519
ER  -

APA

SY, H., HH, L., CW, L., CC, L., M, Y., JL, T., HA, H., W, T., SJ, C., CL, C., & HF, T. (2016). Soluble PD-L1: A biomarker to predict progression of autologous transplantation in patients with multiple myeloma.. Oncotarget. https://doi.org/10.18632/oncotarget.11519

Source records

pubmed · retrieved 2026-09-26T01:10:40.014Z